Clinical trial

Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy

NCT01263444

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE4

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2014-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

Brinzolamide 1% / timolol 0.5% Fixed CombinationDRUG

Habitual prostaglandin monotherapyDRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01263444 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.